LS PHARMA Trademark

Trademark Overview

On Monday, December 4, 2023, a trademark application was filed for LS PHARMA with the United States Patent and Trademark Office. The USPTO has given the LS PHARMA trademark a serial number of 98297376. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, August 29, 2025. This trademark is owned by Lifestyle Compounding LLC. The LS PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating hormonal imbalances, pain management, dermatological conditions, and nutritional deficiencies
ls pharma

General Information

Serial Number98297376
Word MarkLS PHARMA
Filing DateMonday, December 4, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, August 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating hormonal imbalances, pain management, dermatological conditions, and nutritional deficiencies
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 2023
Primary Code005
First Use Anywhere DateWednesday, November 1, 2023
First Use In Commerce DateWednesday, November 1, 2023

Trademark Owner History

Party NameLifestyle Compounding LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlbuquerque, NM 87109
Party NameLifestyle Compounding LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlbuquerque, NM 87109

Trademark Events

Event DateEvent Description
Monday, December 4, 2023NEW APPLICATION ENTERED
Tuesday, February 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 2, 2024ASSIGNED TO EXAMINER
Tuesday, July 2, 2024ASSIGNED TO EXAMINER
Thursday, July 11, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 11, 2024NON-FINAL ACTION E-MAILED
Thursday, July 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 12, 2024FINAL REFUSAL WRITTEN
Tuesday, July 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 12, 2024FINAL REFUSAL E-MAILED
Monday, August 12, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 19, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, September 3, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 3, 2024EXAMINER'S AMENDMENT ENTERED
Monday, August 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, September 3, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 11, 2025USE AMENDMENT FILED
Friday, April 11, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, August 6, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 8, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 6, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 29, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 3, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

pharma dermatological conditions nutritional deficiencies management pain preparations treating hormonal imbalances